IP Library Granted Patent US 9,358,209
Granted Patent B2
US 9,358,209 · App. 13/198,995 · Granted Jun 7, 2016

Econazole composition and methods of treatment therewith

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,358,209
App. No.
13/198,995
Granted
Jun 7, 2016
Kind
B2
Abstract

The invention provides a water-based composition for treating an infection by a dermatophyte fungus comprising econazole or a pharmaceutically acceptable salt thereof. Also provided are methods of treatment utilizing the water-based foam composition, as well as its preparation.

Claims (23)

1. An aerosol canister consisting of:

0.5-1.5% by weight econazole nitrate;

6-8% by weight of stearic acid substantially in an ionized form;

0.9-2.9% by weight of povidone;

6-9% by weight of humectants, the humectants being one or both of propylene glycol and glycerol;

0.5%-2.0% by weight of dimethicone;

2-3% by weight triethanolamine;

1-4% by weight polysorbate 20; and

water; and

one or more propellants;

wherein the composition as a pH in the range of 6-9; and

wherein the weight % of the above ingredients are provided exclusive of the one or more propellants present in the composition.

2. The aerosol canister of claim 1 consisting of:

1.0% by weight econazole nitrate;

8.0% by weight of stearic acid;

1.9% by weight of povidone;

5.8% by weight propylene glycol;

1.7% by weight glycerol;

0.95% by weight of dimethicone;

2.6% by weight triethanolamine;

3.7% by weight polysorbate 20;

water; and

one or more propellants.

Assignments (5)
SECURITY AGREEMENT Recorded Dec 24, 2020
From: RESILIA PHARMACEUTICALS, INC.; PEAK PHARMA COMMERCIAL PARTNERS LLC
To: SG CREDIT PARTNERS
Reel/Frame 054846/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2019
From: EXELTIS USA DERMATOLOGY, INC.
To: PARAGON NORDIC AB
Reel/Frame 048828/0504 →
CHANGE OF NAME Recorded Sep 3, 2015
From: QUINNOVA PHARMACEUTICALS, INC.
To: EXELTIS USA DERMATOLOGY, INC.
Reel/Frame 036541/0336 →
CHANGE OF NAME Recorded Jun 1, 2015
From: EVERETT LABORATORIES, INC.
To: EXELTIS USA, INC.
Reel/Frame 035807/0222 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2011
From: HENSBY, CHRISTOPHER N.; SILVANDER, MATS
To: QUINNOVA PHARMACEUTICALS, INC.
Reel/Frame 026995/0655 →